glycyrrhizic acid has been researched along with amphotericin b in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koyama, O; Kuwahara, E; Ohkubo, K; Takahashi, M; Tanaka, M; Yotsuyanagi, T | 1 |
| Burckhart, MF; Crance, JM; Cuyck-Gandré, HV; Girond, S; Job, A | 1 |
| Koyama, O; Kuwahara, E; Takahashi, M; Takahashi, N; Tanaka, M; Yotsuyanagi, T | 1 |
| Herndon, DN; Kobayashi, M; Pollard, RB; Suzuki, F; Utsunomiya, T | 1 |
| AlQuadeib, BT; Horrocks, B; Radwan, MA; Šiller, L; Wright, MC | 1 |
5 other study(ies) available for glycyrrhizic acid and amphotericin b
| Article | Year |
|---|---|
Effect of glycyrrhizinate on dissolution behavior and rectal absorption of amphotericin B in rabbits.
Topics: Amphotericin B; Animals; Biological Availability; Glycyrrhetinic Acid; Glycyrrhizic Acid; Intestinal Absorption; Male; Rabbits; Rectum; Suppositories | 1992 |
Use of digoxigenin-labeled RNA probe to test hepatitis A virus antiviral drugs.
Topics: Amides; Amphotericin B; Antiviral Agents; Carrageenan; Digoxigenin; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis A Virus, Human; In Vitro Techniques; Nucleic Acid Hybridization; Pyrazoles; Radioimmunoassay; Ribonucleosides; Ribose; RNA Probes | 1995 |
Enhanced rectal absorption of amphotericin B lyophilized with glycyrrhizinate in rabbits.
Topics: Absorption; Amphotericin B; Animals; Antifungal Agents; Freeze Drying; Glycyrrhizic Acid; Male; Rabbits; Rectum; Suppositories; Surface-Active Agents | 1998 |
Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice.
Topics: Amphotericin B; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Burns; Candida albicans; Candidiasis; CD4-Positive T-Lymphocytes; Cytokines; Glycyrrhizic Acid; Mice; Mice, Inbred BALB C | 1999 |
Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Biological Availability; Biomarkers; Blood Urea Nitrogen; Candida albicans; Creatinine; Drug Carriers; Drug Compounding; Glycyrrhizic Acid; Hemolysis; Kidney Diseases; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Technology, Pharmaceutical | 2017 |